“Get Serious or Lose Funding”: Vance Escalates Medicaid Crackdown.
JD Vance warned that states failing to cooperate with the White House’s anti‑fraud campaign could lose Medicaid and Medicare funding, a threat that has already halted hundreds of millions of dollars in Minnesota. Critics argue the administration lacks clear statutory authority to withhold full Medicaid matching funds, making the rhetoric more political than legal. The warning has sparked anxiety among governors, providers, and low‑income patients who rely on federal health programs. The debate highlights a clash between fraud‑prevention goals and the risk of destabilizing essential health services.
WWL Embeds National Clinical Guidance Into Altera Digital Health’s Sunrise EPR to Transform Acute Abdomen Pathway
Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust partnered with Altera Digital Health to embed National Emergency Laparotomy Audit (NELA) guidance into its Sunrise Electronic Patient Record. The integration automated decision support, one‑click CT ordering, and risk scoring, driving...
Isomorphic Labs Pulls $2.1B Series B Led By Thrive With MGX, Temasek, And UK Sovereign AI Fund: What The Capital...
Isomorphic Labs announced a $2.1 billion Series B round led by Thrive, with participation from MGX, Temasek, and the UK Sovereign AI Fund. The funding backs the company’s IsoDDE AI engine for drug discovery, despite having no approved drugs or Phase 2 data....
New Healthcare Apprenticeship Initiative Puts the Focus on Employers
UW Health WorkForward, launched by former National Center for the Apprenticeship Degree leader Eric Dunker, is the first national employer‑led intermediary focused on healthcare apprenticeships. The initiative offers technical assistance, policy advocacy, and research to help hospitals and health systems...
Blood Test Help Personalise Depression Treatment
NeuroKaire, an Israeli startup, has launched BrightKaire—a blood‑based test that uses patient‑derived stem cells to create frontal brain neurons and assess how 70 different antidepressants affect neural connectivity. The test, now approved in Israel and the United States, promises to...
Top 7 Fastest Growing Pharma & Biotech Companies in Asia for 2026
The Financial Times’ 2026 ranking spotlights the seven fastest‑growing Asian pharma and biotech firms, each posting double‑digit revenue surges and landmark milestones. SillaJen earned an FDA IND for its oncolytic virus BAL0891, while Oscotec leveraged lazertinib royalties to boost 2024...
What’s Coming up at SLAS Europe 2026?
The Society for Laboratory Automation and Screening (SLAS) will host its 2026 European Conference and Exhibition in Vienna from May 19‑21, featuring a technology provider showcase at the Vienna BioCenter and a packed scientific program. Highlights include keynote and breakout...
De-CIPHER-Ing Transcriptomes and Proteins Together with New RNA-Seq Technology
Scientists at the Sylvester Comprehensive Cancer Center and UCSF unveiled CIPHER‑seq, a single‑cell platform that simultaneously measures whole‑transcriptome RNA and intracellular proteins. By optimizing fixation, permeabilization and antibody incubation, the method avoids the RNA degradation and stress artifacts that plague...
The Case for Smarter Neuroinflammation Clinical Trials
INmune Bio, led by CEO David Moss, is developing non‑immunosuppressive therapies that target innate immune pathways, including the XPro1595 program for neurodegenerative disease and the CORDStrom mesenchymal stromal cell platform for recessive dystrophic epidermolysis bullosa (RDEB). The company argues that...
Pharma Pulse: The FDA Shake-Up and Growing Frustration with Prior Auth Reform
FDA Commissioner Marty Makary announced his resignation, with deputy Kyle Diamantas stepping in as acting commissioner. Eli Lilly released data indicating patients can sustain weight loss when transitioning from higher‑dose injectables to lower‑dose Zepbound or its oral GLP‑1, Foundayo. The...
Living ‘Tumour on a Chip’ Could Offer New Brain Cancer Insights
Researchers at Nottingham Trent University, in partnership with biotech firm Kirkstall Ltd, have built a living tumour‑on‑chip that mimics the human blood‑brain barrier to study glioblastoma. The microfluidic device cultivates patient‑derived brain‑cancer cells alongside a synthetic barrier, enabling real‑time monitoring...
Viewpoint: ‘Measles Is a Canary in the Healthcare Coal Mine’: Challenging RFK, Jr.’s Scare Campaign
U.S. health officials are alarmed by a sharp uptick in measles cases, describing the outbreak as a “canary in the coal mine” for the nation’s vaccination system. The article attributes the surge largely to a years‑long anti‑vaccine campaign spearheaded by...
Can Clonal Hematopoiesis Improve Blood Cancer Screening?
Clonal hematopoiesis (CH) is emerging as a measurable precursor to aggressive blood cancers such as acute myeloid leukemia (AML). Recent research shows that high‑risk CH mutations can be detected with a simple $250 next‑generation sequencing blood test, and machine‑learning models...
New Blood Test for Early Alzheimer’s Detection with FNIH’s Dr. Alessio Travaglia — Episode 255
A new blood test developed by the Foundation for the National Institutes of Health (FNIH) can predict Alzheimer’s symptom onset three to four years in advance, according to a study published in Nature Medicine. The test leverages a clock‑model biomarker...
International Medical Graduates Need Real Protections
International medical graduates (IMGs) face systemic barriers that left a Fulbright‑trained physician unable to help during the COVID‑19 surge because licensing exams were incomplete. After matching into a prestigious pediatrics residency, the author encountered a hostile culture where dissent was...
Sanofi Bets $294M on Toronto AI Hub
Sanofi is committing roughly US$218 million (CAD 294 million) to expand its Toronto Artificial Intelligence Centre of Excellence, adding 50 machine‑learning positions and bringing its digital workforce in Ontario to more than 150 by 2028. The province is contributing a conditional grant of...
Clarification Needed of NHS Supply Chain Commitment to Value-Based Procurement
A recent NHS Supply Chain article claims value‑based procurement (VBP) will become the backbone of future purchases, yet a cardiology and vascular tender applied a 70% price weighting and a hard price‑threshold that could discard bids regardless of their demonstrated...
AMX-883
Amphista Therapeutics announced AMX-883, an oral degrader that recruits the DCAF16 E3 ligase to eliminate the epigenetic reader BRD9. The preclinical program demonstrates selective BRD9 degradation in acute myeloid leukemia (AML) cell models, leveraging a previously identified BRD9 binder for...
Why Attend the 2026 Canadian Pharma & Biotech PPM Summit Toronto
The Canadian Pharma & Biotech Project, Program and Portfolio Management Summit will convene senior life‑science leaders in Toronto on May 27‑28, 2026. Attendees will explore how to strengthen portfolio performance amid pricing pressure, evolving regulations, and intensified competition for global...
Point-of-Care Ultrasound Transforms Emergency Medicine
Point‑of‑care ultrasound (POCUS) is reshaping emergency medicine by enabling physicians to make bedside diagnoses in real time. Emergency physicians report faster decision‑making, higher patient satisfaction, and a renewed sense of clinical engagement, which counters the specialty’s high burnout rates. Data...
Revvity Receives FDA Clearance for Total Testosterone Assay Enabling Comprehensive Automated Testosterone Testing Solution
Revvity, via its Immunodiagnostic Systems unit, secured FDA clearance for a Total Testosterone chemiluminescence immunoassay (ChLIA). The new assay joins FDA‑cleared free testosterone and SHBG tests, creating the only single‑platform, fully automated testosterone testing suite. The portfolio targets hypogonadism diagnosis...
Calyxo Enters AUA2026 With Its Largest Clinical Evidence Presence to Date and Enhanced Visualization
Calyxo, Inc. will showcase its CVIC System at the American Urological Association’s 2026 meeting, presenting a record ten abstracts that highlight safety, efficacy, and procedural efficiency. The company reports that more than 40,000 patients have been treated with the CVIC...
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions
Charles River Laboratories and South Korean biotech MEDIPOST have signed a non‑exclusive memorandum of understanding to provide GMP‑compliant testing and regulatory support for MEDIPOST’s cell‑therapy pipeline. The collaboration will initially focus on the Asia‑Pacific and North American markets, with the...
Seven Northwell Hospitals Earn CMS 5-Star Ratings
Northwell Health announced that seven of its hospitals earned the highest five‑star rating from the Centers for Medicare & Medicaid Services (CMS) in the 2026 Star Quality Rating System, while five additional facilities received four‑star ratings. This marks the first...
Nursing Engagement Improves While Early-Career Nurse Departures Persist at Alarming Rates
Press Ganey’s State of Nursing 2026, based on more than 500,000 nurses and advanced practice providers, shows overall engagement beginning to stabilize but remaining fragile. Early‑career nurses are still leaving at a rate of one in five, while total RN turnover...
Catalent and Elpida Therapeutics Enter Strategic Partnership for Late-Phase AAV Manufacturing
Elpida Therapeutics and contract manufacturer Catalent have entered a strategic partnership to handle late‑phase manufacturing of Elpida’s lead AAV9 gene therapy for Spastic Paraplegia Type 50 (SPG50). Catalent will also receive exclusive rights to produce Elpida’s other adeno‑associated virus (AAV) programs,...
BIOSECURE and Beyond: What It Really Means for Pharma Supply Chains
The BIOSECURE Act, enacted in early 2026, bars certain foreign biotech providers from U.S. pharmaceutical supply chains, prompting firms to shift production away from long‑haul Asian routes. Companies are diversifying manufacturing footprints toward domestic or allied sites, which reduces concentration...
Five Ways to Start Fixing America’s Health Care System
The article outlines five legislative steps to begin fixing America’s health‑care system. It calls for breaking up vertically integrated insurers such as UnitedHealth, treating insurance medical directors as practicing physicians, and enforcing antitrust rules using the Herfindahl‑Hirschman Index. It also...
Forus Raises US$160m for AI-Powered Medicine Platform
Formerly known as Tandem, Forus announced a $160 million funding round led by Thrive Capital, General Catalyst, Accel and other top VCs to scale its AI‑powered platform that links doctors, payers, pharmacies and biopharma. The platform automates insurance authorisation, financial assistance...
Nursing Violence Causes Silent and Painful Cumulative Stress
Veteran psychiatric nurse Adam J. Wickett reveals that violence—both patient‑initiated and staff‑to‑staff—has become a silent, under‑reported reality in nursing environments. Over two decades he witnessed threats, lock‑downs, shattered windshields and even near‑fatal car incidents, all of which leave nurses in...
ECO2026: Lilly Gets Serious About Long-Term Obesity Care
At ECO2026 in Istanbul, Eli Lilly unveiled data from two landmark trials that reposition obesity as a chronic condition requiring sustained therapy. The SURMOUNT‑MAINTAIN study in The Lancet showed participants who continued full‑dose tirzepatide for 60 weeks largely preserved weight loss and...
The Next Wave of Healthcare Cyber Risk, From IoMT to AI-Enabled Attacks
Healthcare cyber risk is evolving beyond ransomware and data breaches as connected medical devices, remote telehealth services, and cloud platforms expand the attack surface. Legacy equipment lacking modern security controls now coexists with IoT and OT, creating vulnerable footholds for...
Makary Out at FDA. Independent Doctors Urge the Next Commissioner to Confront America’s Prescription Drug Crisis — and End Big...
The Independent Medical Alliance (IMA) is urging the White House to appoint a new FDA commissioner who will prioritize patient safety over pharmaceutical profits following Marty Makary's departure. IMA’s president, Dr. Joseph Varon, highlighted that 69% of American adults take...
Hey, FDA Commissioner Makary, AI Has a Wild Idea – Perhaps a Hallucination?
FDA Commissioner Robert Makary resigned on May 12, 2026 amid internal tensions and a vaping‑policy dispute. The article examines a hypothetical replacement: food‑safety attorney Bill Marler, known for winning over $850 million in food‑borne illness settlements. It outlines Marler’s deep expertise...
Diabetes Reversed by Stem Cell-Derived Islets, Illustrating Promise for New Therapy
Researchers at Karolinska Institutet and KTH have devised a streamlined protocol that converts eight human pluripotent stem cell lines into highly pure, glucose‑responsive pancreatic islet cells. The cells produce insulin in vitro and, when transplanted into the eyes of diabetic...
Republicans Repeat Problematic Estimate of Medication Abortion Harms
Republican lawmakers have revived a claim that at least 10 % of women experience serious side effects from the abortion pill mifepristone. The figure stems from a 2025 anti‑abortion report criticized for opaque methods and selective data. Peer‑reviewed research consistently shows...
Scientists Say This Simple Supplement May Actually Reverse Heart Disease
Japanese researchers at Osaka University reported that the dietary supplement tricaprin markedly reduced arterial triglyceride deposits in two patients with triglyceride deposit cardiomyovasculopathy (TGCV), a rare, treatment‑resistant form of coronary artery disease. Imaging showed widened coronary lumens and decreased lipid...
Dual-Ligase Strategy Adds New Layer of Control to Targeted Protein Degradation
Researchers at CeMM, AITHYRA and the University of Dundee have identified a small‑molecule degrader that simultaneously engages two distinct E3 ligases to eliminate SMARCA2/4, key subunits of the BAF chromatin‑remodeling complex. The dual‑ligase mechanism acts as a molecular backup: degradation...
DOJ Announces New West Coast Health Care Fraud Strike Force
On April 30, 2026 the Justice Department launched the West Coast Health Care Fraud Strike Force, a multi‑district effort covering Arizona, Nevada and the Northern District of California. The initiative pairs the Fraud Division’s health‑care team with local U.S. Attorneys...
Tom Brady Is Pitching a GLP-1 Benefit for Healthcare Workers
Tom Brady, now an investor and chief wellness officer at eMed, has launched a GLP-1 benefit aimed at healthcare workers. The program offers FDA‑approved GLP‑1 medications for $99 a month per eligible employee, with employers paying $25 per covered life...
The Hidden Rule Makers Behind Prior Auth and Claim Denials: How InterQual, MCG, HealthEdge, Zelis, Lyric, and Optum’s CES Write...
The article reveals that a handful of technology vendors—InterQual, MCG, Optum’s CES, Lyric, HealthEdge and Zelis—write the clinical criteria that drive most prior‑authorization and claim‑denial decisions. InterQual and MCG together command roughly 90% of the prior‑auth rule market, while the...
If You’re Going to Remove the Clinician, You Have to Think Like a Clinician (and Ride Your Bike)
The author recounts a personal health alert after a bike ride, where his KardiaMobile 6L’s AI flagged a wide QRS complex despite a normal sinus rhythm history. A cardiologist’s overread deemed the reading normal, underscoring the tension between AI‑driven wearables...
Maximizing Drug Impact
Tris Pharmaceutical, founded by CEO Ketan Mehta, has evolved from an oral‑technology specialist to a broader portfolio that now includes pain‑management and addiction therapies. Mehta explained that the company tackles drug‑impact challenges by engineering particle‑based delivery systems that provide continuous,...
Media Spreads Hantavirus Hysteria In Attempt To Save Disgraced WHO
The media amplified a recent hantavirus case on a cruise from Argentina to West Africa, framing it as a looming public‑health crisis. The coverage coincides with the World Health Organization’s severe funding shortfall after the United States withdrew, leaving the...
Can Medical Schools Really Teach 71 Nutrition ‘Competencies’? Should They?
The U.S. Department of Health and Human Services unveiled a Medical Education Nutrition Competency Framework that outlines 10 domains and 71 specific competencies, requiring a minimum of 40 instructional hours for undergraduate medical students. HHS Secretary Robert F. Kennedy Jr....
RESEARCH: TOCOTRIENOLS in COLORECTAL CANCER - 2024 Review Paper From Malaysia
A 2024 review from Malaysia examined 38 peer‑reviewed articles on tocotrienols, a subclass of vitamin E, and their effects on colorectal cancer. The analysis highlighted two isoforms, gamma‑ and delta‑tocotrienol, which consistently inhibited tumor cell proliferation, induced apoptosis, and reduced metastatic...
Hantavirus Outbreak Research: Trump Administration Shut Down Study Last Year on Rodent-to-Human Transmission
In 2025 the Trump administration terminated funding for a pilot project that examined how hantavirus moves from rodents to humans. The study, run by the West African Center for Emerging Infectious Diseases, was part of the ten‑site CREID network that...
“Evidence for Puberty Suppression and Gender Affirming Hormones Limited’: British Doctors Group Questions Early Transitions but Also Opposes Blocker Ban
The British Medical Association (BMA) released a critique of the Cass review, reaffirming that the scientific evidence for puberty suppression and gender‑affirming hormones in young people is limited and uncertain. While the BMA acknowledges genuine risks such as osteoporosis and...
Anti-Vax Activists Falsely Blame COVID Vaccines for the Rising U.S. Cancer Rate Among Younger People.
The National Cancer Institute released data covering 2000‑2023 that show a steady rise in early‑onset cancers—those diagnosed in people under 50—in the United States. Anti‑vaccine activists seized on a 6.37% increase recorded between 2021 and 2023, a period coinciding with...
Just Like Cigarettes, Vaping Likely Causes Cancer, Major Study Finds
A comprehensive 2026 review in the journal Carcinogenesis concluded that e‑cigarettes are likely to cause lung and oral cancer. The analysis integrated human biomarker data, laboratory experiments, and animal studies, all showing DNA damage, oxidative stress, inflammation, and tumor formation...